COMPANY
BrainsWay
FDA-cleared device company Past trials only
Timeline
- Raise Private placement: $6M (total, as published), announced Mar 26, 2026. Source: SEC filing. source ↗
- Trial start Not phased (device or behavioral study): Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD) source ↗
- Grant Government grant: $2.5M (total, as published), announced Nov 4, 2025. Source: SEC filing. source ↗
- Raise Private placement: $5M (total, as published), announced Jun 4, 2025. Source: SEC filing. source ↗
- Trial start Not phased (device or behavioral study): New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD) source ↗
- Trial start Not phased (device or behavioral study): Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects source ↗
- Trial start Phase 1: Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment source ↗
- Trial start —: Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD) source ↗
- Trial start Phase 4: Brainsway DTMS for Treatment of MDD Using iTBS source ↗
- Trial start Not phased (device or behavioral study): Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD) source ↗
- Trial start Not phased (device or behavioral study): A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD) source ↗
- Trial start Not phased (device or behavioral study): Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual source ↗
- Trial start Not phased (device or behavioral study): An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD source ↗
- Trial start Phase 3: Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation. source ↗
- Trial start Phase 2: The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease source ↗
- Trial start Phase 2: Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus. source ↗
- Trial start Phase 2: Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children. source ↗
- Trial start Early phase 1: Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe source ↗
- Trial start Not phased (device or behavioral study): Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression source ↗
- Trial start Not phased (device or behavioral study): Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) source ↗
- Trial start Phase 1: Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults source ↗
- Trial start Not phased (device or behavioral study): Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects source ↗
- Trial start Phase 2: Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease source ↗
- Trial start Not phased (device or behavioral study): Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder source ↗
Upcoming milestones
- Nov 1, 2027 (ESTIMATED) · Not phased · Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD) · NCT07216872
Funding
Clinical trials (lead sponsor) 21
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07216872 | Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD) | Not phased (device or behavioral study) | Recruiting | Nov 7, 2025 | Nov 1, 2027 (estimated) |
| NCT06357832 | New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD) | Not phased (device or behavioral study) | Completed | Apr 29, 2024 | Feb 26, 2025 (actual) |
| NCT05404360 | Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | 2022-08 | 2024-06 (estimated) |
| NCT02260765 | Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual | Not phased (device or behavioral study) | Withdrawn | 2014-10 | 2020-09 (estimated) |
| NCT01566591 | Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | 2012-05 | 2021-12 (estimated) |
| NCT04679753 | Brainsway DTMS for Treatment of MDD Using iTBS | Phase 4 | Completed | Jan 1, 2019 | Jul 1, 2020 (actual) |
| NCT02126124 | Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation. | Phase 3 | Completed | Aug 20, 2014 | Nov 14, 2019 (actual) |
| NCT00927173 | Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder | Not phased (device or behavioral study) | Completed | 2009-09 | 2012-03 (actual) |
| NCT02229903 | An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD | Not phased (device or behavioral study) | Completed | 2014-09 | 2017-06 (actual) |
| NCT03012724 | Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD) | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | Mar 30, 2017 | 2020-12 (estimated) |
| NCT01361815 | Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) | Not phased (device or behavioral study) | Completed | 2011-07 | 2014-12 (actual) |
| NCT01196910 | Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults | Phase 1 | Unknown status (ClinicalTrials.gov) | 2011-07 | 2020-09 (estimated) |
| NCT01464515 | Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment | Phase 1 | Unknown status (ClinicalTrials.gov) | 2021-01 | 2021-01 (estimated) |
| NCT01343732 | Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | 2011-06 | 2020-11 (estimated) |
| NCT04455646 | Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD) | Not listed | Unknown status (ClinicalTrials.gov) | Aug 26, 2019 | Aug 26, 2021 (estimated) |
| NCT02479906 | A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD) | Not phased (device or behavioral study) | Terminated | Nov 17, 2016 | Feb 6, 2020 (actual) |
| NCT01388179 | Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children. | Phase 2 | Terminated | Jan 23, 2013 | Dec 31, 2016 (actual) |
| NCT02039206 | The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease | Phase 2 | Completed | 2014-02 | 2015-02 (actual) |
| NCT01599208 | Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe | Early phase 1 | Withdrawn | 2012-08 | 2015-01 (estimated) |
| NCT01179373 | Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease | Phase 2 | Completed | 2010-08 | 2015-01 (actual) |
| NCT02053961 | Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus. | Phase 2 | Withdrawn | 2014-01 | 2016-01 (estimated) |
Raises and investors new
- Raise Private raise (SEC Form D): $20.0M sold; issuer “Brainsway Ltd.”. Verified from the SEC filing. SEC filing ↗
Connect
See your connections at BrainsWay on LinkedIn (search by name, results not checked)